This list is an analysis based on recent market events. It's not an investment recommendation.
About
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
What is Artiva Biotherapeutics stock price today?▼
The current price of ARTV.BOATS is $4.18 USD — it has decreased by -1.18% in the past 24 hours. Watch Artiva Biotherapeutics stock price performance more closely on the chart.
What is Artiva Biotherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Artiva Biotherapeutics stocks are traded under the ticker ARTV.BOATS.
What is Artiva Biotherapeutics market cap?▼
Today Artiva Biotherapeutics has the market capitalization of 204.36M
When is the next Artiva Biotherapeutics earnings date?▼
Artiva Biotherapeutics is going to release the next earnings report on November 18, 2026.
What were Artiva Biotherapeutics earnings last quarter?▼
ARTV.BOATS earnings for the last quarter are -0.63 USD per share, whereas the estimation was -0.63 USD resulting in a -0.79% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Artiva Biotherapeutics revenue for the last year?▼
Artiva Biotherapeutics revenue for the last year amounts to 0 USD.
What is Artiva Biotherapeutics net income for the last year?▼
ARTV.BOATS net income for the last year is -83.87M USD.
In which sector is Artiva Biotherapeutics located?▼
Artiva Biotherapeutics operates in the Other sector.
When did Artiva Biotherapeutics complete a stock split?▼
Artiva Biotherapeutics has not had any recent stock splits.